Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic

Volume: 420, Pages: 117230 - 117230
Published: Jan 1, 2021
Abstract
ObjectiveTo study the risk of acquiring Corona Virus Disease 2019 (COVID-19) and its outcomes in patients on immunosuppressive therapy (IST) for chronic autoimmune neuromuscular disorders (aNMD) and multiple sclerosis (MS).MethodsWe used TriNetX, a global health collaborative clinical research platform collecting real-time electronic medical records data, which has one of the largest known global COVID-19 database. We included patients with...
Paper Details
Title
Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
Published Date
Jan 1, 2021
Volume
420
Pages
117230 - 117230
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.